An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study
Share
Study at a glance
- Area
- Depression & Mood
- Study type
- Pilot / open study
- Authors
- Spronk D, Arns M, Barnett KJ, Cooper NJ, Gordon E
- Journal
- Journal of Affective Disorders
- Year
- 2011
- Participants
- 25 patients with major depressive disorder (ages 18-65)
- Population
- Adults
- Protocol
- QEEG, ERP, genetic and neuropsychological markers of antidepressant response
Key findings
- Better outcome was linked to a reduced auditory oddball N1 amplitude at baseline
- The Met/Met variant of the COMT gene was the strongest genetic predictor
- Impaired verbal memory was the best cognitive predictor, and raised frontal theta power the best EEG predictor
- Combining N1 amplitude at Pz with verbal memory explained the largest share of variance
A pilot study of whether brain, genetic and cognitive measures can predict how well people with major depressive disorder respond to antidepressant medication. Twenty-five patients completed QEEG, event-related potential (ERP) and neuropsychological testing before treatment and at an 8-week follow-up, and gave cheek swabs for genetic analysis. Regression models identified which markers best predicted the drop in Hamilton Depression Rating Scale (HAM-D) scores. The authors suggest these markers could serve as new predictors of antidepressant outcome.